Search results
Every summer, 18 high school students spend six weeks at Broad working side-by-side with mentors on cutting-edge research. Broad Institute is a multidisciplinary community of researchers on a mission to improve human health.
The Broad Institute of MIT and Harvard is a research organization that convenes a community of researchers from across many disciplines and partner institutions—MIT, Harvard, and Harvard-affiliated hospitals.
The Eli and Edythe L. Broad Institute of MIT and Harvard (IPA: / b r oʊ d /, pronunciation respelling: BROHD), often referred to as the Broad Institute, is a biomedical and genomic research center located in Cambridge, Massachusetts, United States.
The Broad Institute of MIT and Harvard seeks to transform medicine by empowering creative and energetic scientists of all disciplines from across the MIT, Harvard, and the Harvard-affiliated hospital communities to work together to address even the most difficult challenges in biomedical research.
See what Broad is all about. Through virtual experiences and on-site visits, we invite you to learn more about our mission, our work, and how the science we do affects people around the block and around the world.
Through programs spanning genetics, biology, and therapeutic development, Broad researchers are making discoveries that drive biomedical science forward. We aim to expand science's understanding of the fundamental basis of genome and cell biology, and to develop transformative new approaches to biomedical research and therapeutic development.
Over the past ten years, The Genomics Platform has been the largest producer of human genomic information in the world. Currently, the group produces approximately 500 terabases of genomic data per month — a rate equivalent to one 30X human whole genome every 10 minutes.
Welcome to the Broad Institute of MIT and Harvard!
The Broad Institute is a non-profit research organization that convenes academic investigators and professional scientists from around Boston and around the world, removing roadblocks so that...
6 days ago · Researchers at the Broad Institute of MIT and Harvard have developed AI models that can screen the potential biological effects of drugs before they ever enter a living organism. Srijit Seal, a visiting scholar at the Carpenter-Singh Lab in the Broad's Imaging Platform , trained multiple predictive machine learning models to identify chemical and structural drug features likely to cause toxic ...
